Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer

Gender is increasingly recognized as an important factor in medicine, although it has long been neglected in medical research in many areas. We have studied the influence of gender in advanced rectal cancer with a special focus on radiosensitivity. For this purpose, we studied a cohort of 495 men (8...

Full description

Bibliographic Details
Main Authors: Barbara Schuster, Markus Hecht, Manfred Schmidt, Marlen Haderlein, Tina Jost, Maike Büttner-Herold, Klaus Weber, Axel Denz, Robert Grützmann, Arndt Hartmann, Hans Geinitz, Rainer Fietkau, Luitpold V. Distel
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/1/148
_version_ 1797499410981060608
author Barbara Schuster
Markus Hecht
Manfred Schmidt
Marlen Haderlein
Tina Jost
Maike Büttner-Herold
Klaus Weber
Axel Denz
Robert Grützmann
Arndt Hartmann
Hans Geinitz
Rainer Fietkau
Luitpold V. Distel
author_facet Barbara Schuster
Markus Hecht
Manfred Schmidt
Marlen Haderlein
Tina Jost
Maike Büttner-Herold
Klaus Weber
Axel Denz
Robert Grützmann
Arndt Hartmann
Hans Geinitz
Rainer Fietkau
Luitpold V. Distel
author_sort Barbara Schuster
collection DOAJ
description Gender is increasingly recognized as an important factor in medicine, although it has long been neglected in medical research in many areas. We have studied the influence of gender in advanced rectal cancer with a special focus on radiosensitivity. For this purpose, we studied a cohort of 495 men (84.1% ≥ T3, 63.6% N1, 17.6%, M1) and 215 women (84.2% ≥ T3, 56.7% N1, 22.8%, M1) who all suffered from advanced rectal cancer and were treated with radiochemotherapy. The energy deposited, DNA double-strand break (dsb) repair, occurrence of chromosomal aberrations, duration of therapy, tumor regression and tumor-infiltrating lymphocytes, laboratory parameters, quality of life and survival were assessed. The residual DNA dsb damage 24 h after irradiation in lymphocytes was identical in both sexes. Furthermore, chromosomal aberrations accurately reflecting radiosensitivity, were similar in both sexes. There were no gender-dependent differences in tumor regression, tumor-infiltrating lymphocytes and outcome indicating no differences in the radiosensitivity of cancer cells. The irradiated tumor volume in women was slightly lower than in men, related to body weight, no difference was observed. However, when the total energy deposited was calculated and related to the body weight, women were exposed to higher amounts of ionizing radiation. During radiochemotherapy, decreases in blood lymphocyte counts and albumin and several quality-of-life parameters such as nausea and vomiting, loss of appetite, and diarrhea were significantly worse in women. There is no difference in radiation sensitivity between men and women in both normal tissue and tumors. During radiochemotherapy, the quality of life deteriorates more in women than in men. However, women also recover quickly and there are no long-term differences in quality of life.
first_indexed 2024-03-10T03:46:58Z
format Article
id doaj.art-04a5104db7ee45a1a1fb2d71e24977e6
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T03:46:58Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-04a5104db7ee45a1a1fb2d71e24977e62023-11-23T11:16:50ZengMDPI AGCancers2072-66942021-12-0114114810.3390/cancers14010148Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal CancerBarbara Schuster0Markus Hecht1Manfred Schmidt2Marlen Haderlein3Tina Jost4Maike Büttner-Herold5Klaus Weber6Axel Denz7Robert Grützmann8Arndt Hartmann9Hans Geinitz10Rainer Fietkau11Luitpold V. Distel12Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyComprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Ordensklinikum Linz, Barmherzige Schwestern, 4010 Linz, AustriaDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyDepartment of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, GermanyGender is increasingly recognized as an important factor in medicine, although it has long been neglected in medical research in many areas. We have studied the influence of gender in advanced rectal cancer with a special focus on radiosensitivity. For this purpose, we studied a cohort of 495 men (84.1% ≥ T3, 63.6% N1, 17.6%, M1) and 215 women (84.2% ≥ T3, 56.7% N1, 22.8%, M1) who all suffered from advanced rectal cancer and were treated with radiochemotherapy. The energy deposited, DNA double-strand break (dsb) repair, occurrence of chromosomal aberrations, duration of therapy, tumor regression and tumor-infiltrating lymphocytes, laboratory parameters, quality of life and survival were assessed. The residual DNA dsb damage 24 h after irradiation in lymphocytes was identical in both sexes. Furthermore, chromosomal aberrations accurately reflecting radiosensitivity, were similar in both sexes. There were no gender-dependent differences in tumor regression, tumor-infiltrating lymphocytes and outcome indicating no differences in the radiosensitivity of cancer cells. The irradiated tumor volume in women was slightly lower than in men, related to body weight, no difference was observed. However, when the total energy deposited was calculated and related to the body weight, women were exposed to higher amounts of ionizing radiation. During radiochemotherapy, decreases in blood lymphocyte counts and albumin and several quality-of-life parameters such as nausea and vomiting, loss of appetite, and diarrhea were significantly worse in women. There is no difference in radiation sensitivity between men and women in both normal tissue and tumors. During radiochemotherapy, the quality of life deteriorates more in women than in men. However, women also recover quickly and there are no long-term differences in quality of life.https://www.mdpi.com/2072-6694/14/1/148genderrectal cancerradiochemotherapyradiosensitivityDNA double-strand breaksradiosensitivity
spellingShingle Barbara Schuster
Markus Hecht
Manfred Schmidt
Marlen Haderlein
Tina Jost
Maike Büttner-Herold
Klaus Weber
Axel Denz
Robert Grützmann
Arndt Hartmann
Hans Geinitz
Rainer Fietkau
Luitpold V. Distel
Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
Cancers
gender
rectal cancer
radiochemotherapy
radiosensitivity
DNA double-strand breaks
radiosensitivity
title Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
title_full Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
title_fullStr Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
title_full_unstemmed Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
title_short Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
title_sort influence of gender on radiosensitivity during radiochemotherapy of advanced rectal cancer
topic gender
rectal cancer
radiochemotherapy
radiosensitivity
DNA double-strand breaks
radiosensitivity
url https://www.mdpi.com/2072-6694/14/1/148
work_keys_str_mv AT barbaraschuster influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT markushecht influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT manfredschmidt influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT marlenhaderlein influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT tinajost influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT maikebuttnerherold influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT klausweber influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT axeldenz influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT robertgrutzmann influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT arndthartmann influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT hansgeinitz influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT rainerfietkau influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer
AT luitpoldvdistel influenceofgenderonradiosensitivityduringradiochemotherapyofadvancedrectalcancer